Index of Articles From 1994 TAGlines

About TAGlines

December, 1994
- Protease Scoreboard
  Planning for Efficacy Rates of 30-50%, Roche Protease Trials Shoot for Distant Stars
- The Imperiled NCDDG
  Twilight of NIH Drug Discovery Program Will Mean Even Slimmer Pickings for AIDS Therapeutic Pipeline
- Random Gleanings Vaccine Victory (Of Sorts), Inching Closer To An Animal Model for HIV, G.D. Searle's lead protease inhibitor crashed and burned...
November, 1994
- Interleukin-2: An Update
  Ten Years On, Feckless IL-2 Researchers Plod Ahead, Certain Of Success
- ACTG: Re-competition Blues
  Dazed and Confused, ACTG "Re"-Competitors Ready Themselves For The 1996-2001 Funding Cycle
- Yokohama: Malignancy Reportage
  Brouhaha Over Human Chorionic Gonadotropin (hCG) Yields, Again, To Sober Realism
October, 1994
- Star Gazing at the FDA
  Public Hearings At FDA Juxtapose Old Cries of Access With Those of Integrity, Accountability
- Yokohama Pathogenesis Update
  Improved Clinical Outcomes Wrought By Immunosuppressive Medicine and Second-Rate Immune Responses - Where Will It All End?
- The KS Project Report
  Research Paper Details Advances, Obstacles In The Treatment of Kaposi's Sarcoma
September, 1994
- Merck's Protease Plans
  Shot Down Early On, Merck Scientists Test Higher Doses And Combinations, Hoping for Success
- When (Not) To Start ARV Therapy
  Yokohama Roundtable Examines Treatment Quandary Facing Patients, Clinicians Alike
August, 1994
- Shiftless Cytokines
  Series of Research Papers Take To Task Would-Be Discoverers Of Cytokine Switch Scrutinizing the Knock-out Mice
- The Body in Question
  Garbage In, Garbage Out; Could It Be We're Asking Good Questions Of Bad Systems?
- Letter From Rockville
  Another meeting with the (FDA) Commissioner, Rockville, MD, 11 July 1994
July, 1994
- Not So Fast!
  With Its First Protease Trial Completed, Roche Races to FDA With Lukewarm Results, While Activists Cry 'Foul'
- Vaccine Dismay
  NIAID Scraps Large Scale Vaccine Trial -- And A Chastened Genentech Takes Its Case to The Hill
- ACTG Rescue Plan
  Tome of Recommendations Would Abolish ACDDC, Mandate Costing-Out and Establish Advisory Review Group
- A Word About TAG
  Information about TAG
June, 1994
- ACTG: Feet to the Fire
  Feet to the Fire, ACTG Investigators Scramble to Convince Industry They Can Produce
- The Intra-Company Cooperative
  ICC's Brainchild Designed to Show Every Drug and Every Combination a Success. Who Could Complain About That?
- d4T Approval Looms
  Accelerated Approval Guidelines Expedite Bristol's Launch of New Nucleoside -- In the Absence of Any Proof That It Works
May, 1994
- Targeting Kaposi's
  KS Proves Formidable Foe As Angiogenesis Inhibitors and Stealth Chemotherapy Fall Short of Expectations
- The Protease Quandary
  One Company's Search for an Effective Antiviral Contrasts Another's Scramble for the Easy Money
- Gene Therapy Redux
  Table
- Vexed Virologists
  Study After Study, Antiretroviral Analyses Confound More Than They Clarify

Back to the Treatment Action Group index page

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

In Search of a Cure: Working to Turn on HIV

HIV Antiretrovirals in Development: An Update From ICAAC 2009

AIDS Criminals and Innocent Victims: Is There Anything Wrong With This Picture? A Blog Entry by Catherine Hanssens, Esq.

Obama Announces Ryan White CARE Act Reauthorization, Elimination of HIV Travel Ban

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.